- Home
- SLRX vs ENTO Comparison
SLRX vs ENTO Comparison
Compare SLRX & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- ENTO
- Stock Information
- Founded
- SLRX N/A
- ENTO 2014
- Country
- SLRX United States
- ENTO United States
- Employees
- SLRX N/A
- ENTO N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- ENTO Biotechnology: Pharmaceutical Preparations
- Sector
- SLRX Health Care
- ENTO Health Care
- Exchange
- SLRX Nasdaq
- ENTO Nasdaq
- Market Cap
- SLRX N/A
- ENTO 1.7M
- IPO Year
- SLRX N/A
- ENTO 2016
- Fundamental
- Price
- SLRX $0.78
- ENTO $0.40
- Analyst Decision
- SLRX
- ENTO
- Analyst Count
- SLRX 0
- ENTO 0
- Target Price
- SLRX N/A
- ENTO N/A
- AVG Volume (30 Days)
- SLRX 45.8K
- ENTO 90.3K
- Earning Date
- SLRX 05-16-2025
- ENTO 05-20-2025
- Dividend Yield
- SLRX N/A
- ENTO N/A
- EPS Growth
- SLRX N/A
- ENTO N/A
- EPS
- SLRX N/A
- ENTO N/A
- Revenue
- SLRX N/A
- ENTO N/A
- Revenue This Year
- SLRX N/A
- ENTO N/A
- Revenue Next Year
- SLRX N/A
- ENTO N/A
- P/E Ratio
- SLRX N/A
- ENTO N/A
- Revenue Growth
- SLRX N/A
- ENTO N/A
- 52 Week Low
- SLRX $0.45
- ENTO $0.19
- 52 Week High
- SLRX $7.20
- ENTO $3.16
- Technical
- Relative Strength Index (RSI)
- SLRX 52.56
- ENTO 50.28
- Support Level
- SLRX $0.68
- ENTO $0.32
- Resistance Level
- SLRX $0.74
- ENTO $0.37
- Average True Range (ATR)
- SLRX 0.05
- ENTO 0.03
- MACD
- SLRX 0.02
- ENTO 0.01
- Stochastic Oscillator
- SLRX 100.00
- ENTO 84.02
About ENTO Entero Therapeutics Inc. Common Stock
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.